87 related articles for article (PubMed ID: 29097203)
21. TGF-β1/PTEN/PI3K signaling plays a critical role in the anti-proliferation effect of tetrandrine in human colon cancer cells.
Chen QZ; Li Y; Shao Y; Zeng YH; Ren WY; Liu RX; Zhou LY; Hu XL; Huang M; He F; Sun WJ; Wu K; He BC
Int J Oncol; 2017 Mar; 50(3):1011-1021. PubMed ID: 28197642
[TBL] [Abstract][Full Text] [Related]
22. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
Mirzoeva S; Franzen CA; Pelling JC
Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
[TBL] [Abstract][Full Text] [Related]
23. AMPK inhibits Smad3-mediated autoinduction of TGF-β1 in gastric cancer cells.
Zou J; Li C; Jiang S; Luo L; Yan X; Huang D; Luo Z
J Cell Mol Med; 2021 Mar; 25(6):2806-2815. PubMed ID: 33538080
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
[TBL] [Abstract][Full Text] [Related]
25. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
26. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
27. Ox-LDL-induced TGF-β1 production in human alveolar epithelial cells: involvement of the Ras/ERK/PLTP pathway.
Guo LL; Chen YJ; Wang T; An J; Wang CN; Shen YC; Yang T; Zhao L; Zuo QN; Zhang XH; Xu D; Wen FQ
J Cell Physiol; 2012 Sep; 227(9):3185-91. PubMed ID: 22034170
[TBL] [Abstract][Full Text] [Related]
28. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action.
Bartscht T; Rosien B; Rades D; Kaufmann R; Biersack H; Lehnert H; Gieseler F; Ungefroren H
Mol Cancer; 2015 Nov; 14():199. PubMed ID: 26588899
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-{beta}-inducible phosphorylation of Smad3.
Wang G; Matsuura I; He D; Liu F
J Biol Chem; 2009 Apr; 284(15):9663-73. PubMed ID: 19218245
[TBL] [Abstract][Full Text] [Related]
30. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression.
Jinnin M; Ihn H; Tamaki K
Mol Pharmacol; 2006 Feb; 69(2):597-607. PubMed ID: 16288083
[TBL] [Abstract][Full Text] [Related]
31. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway.
Qu Y; Zhang L; Kang Z; Jiang W; Lv C
Pulm Pharmacol Ther; 2015 Oct; 34():1-7. PubMed ID: 26254990
[TBL] [Abstract][Full Text] [Related]
32. DEDD negatively regulates transforming growth factor-beta1 signaling by interacting with Smad3.
Xue JF; Hua F; Lv Q; Lin H; Wang ZY; Yan J; Liu JW; Lv XX; Yang HZ; Hu ZW
FEBS Lett; 2010 Jul; 584(14):3028-34. PubMed ID: 20553715
[TBL] [Abstract][Full Text] [Related]
33. SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.
Kocic J; Bugarski D; Santibanez JF
Eur J Cancer; 2012 Jul; 48(10):1550-7. PubMed ID: 21798735
[TBL] [Abstract][Full Text] [Related]
34. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
35. c-Ski inhibits the proliferation of vascular smooth muscle cells via suppressing Smad3 signaling but stimulating p38 pathway.
Li J; Li P; Zhang Y; Li GB; Zhou YG; Yang K; Dai SS
Cell Signal; 2013 Jan; 25(1):159-67. PubMed ID: 22986000
[TBL] [Abstract][Full Text] [Related]
36. Histone demethylase RBP2 promotes malignant progression of gastric cancer through TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit.
Liang X; Zeng J; Wang L; Shen L; Ma X; Li S; Wu Y; Ma L; Ci X; Guo Q; Jia M; Shen H; Sun Y; Liu Z; Liu S; Li W; Yu H; Chen C; Jia J
Oncotarget; 2015 Jul; 6(19):17661-74. PubMed ID: 25974964
[TBL] [Abstract][Full Text] [Related]
37. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
[TBL] [Abstract][Full Text] [Related]
38. Crosstalk between p38 and Smad3 through TGF-β1 in JEG-3 choriocarcinoma cells.
Xu Q; Tan Y; Zhang K; Li Y
Int J Oncol; 2013 Oct; 43(4):1187-93. PubMed ID: 23877620
[TBL] [Abstract][Full Text] [Related]
39. VEGF suppresses epithelial-mesenchymal transition by inhibiting the expression of Smad3 and miR‑192, a Smad3-dependent microRNA.
Hong JP; Li XM; Li MX; Zheng FL
Int J Mol Med; 2013 Jun; 31(6):1436-42. PubMed ID: 23588932
[TBL] [Abstract][Full Text] [Related]
40. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
